Absence of bioactivity of lipid derivatives of serotonin

European Journal of Medical Research

Volumn 15, Issue 2, 2010, Pages 1-7

  Pozdzik, M ^a   Zajac, D ^a   Zasada, I ^a   Czarnocki, Z ^b   Matysiak, Z ^c   Mazzatenta, A ^d   Pokorski, M ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

^c INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^d UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; CAPROLIC AMIDE; FATTY ACID; LIPID; OCTANOIC ACID; OLEIC ACID; SATURATED FATTY ACID; SEROTONIN; SEROTONIN DERIVATIVE; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; DRUG DERIVATIVE; HEXANOIC ACID DERIVATIVE; OCTANOIC ACID DERIVATIVE;

ADULT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOLOGICAL ACTIVITY; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; BRAIN FUNCTION; BRAIN PENETRATION; BREATHING; CHEMORECEPTOR REFLEX; CONTROLLED STUDY; FUNCTIONAL ASSESSMENT; HYPOXIA; HYPOXIC VENTILATORY RESPONSE; IN VITRO STUDY; LIPOPHILICITY; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RESPIRATORY TRACT PARAMETERS; ANIMAL; BLOOD BRAIN BARRIER; BRAIN; CAROTID BODY; DRUG STABILITY; MALE; METABOLISM; WISTAR RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CAPROATES; CAPRYLATES; CAROTID BODY; DRUG STABILITY; FATTY ACIDS; MALE; OLEIC ACIDS; RATS; RATS, WISTAR; SEROTONIN;

EID: 84962556024     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-15-S2-128     Document Type: Article

References (33)

1. Mohamed-Zadeh L, Moses L, Gwaltney-Brant S: Serotonin: A review. J Vet Pharmacol Therap 2008, 31: 187-99. 10.1111/j.1365-2885.2008.00944.x
2. Green A: Neuropharmacology of 5-hydroxytyramine. Br J Pharmacol 2006, 147: S145-52.
3. Richmonds CR, Hudgel DW: Hypoglossal and phrenic motoneuron responses to serotonergic active agents in rats. Respir Physiol 1996, 106: 153-60. 10.1016/S0034-5687(96)00079-5
4. Lindsay AD, Feldman JL: Modulation of respiratory activity of neonatal rat phrenic motoneurones by serotonin. J Physiol (Lond) 1993, 461: 213-33.
5. Morin D, Monteau R, Hilaire G: Compared effects of serotonin on cervical and hypoglossal inspiratory activities: an in vitro study in the newborn rat. J Physiol (Lond) 1992, 451: 605-29.
6. Jacobs BL, Azmitia EC: Structure and function of the brain serotonin system. Physiol Rev 1992, 75: 165-229.
7. Kinkead R, Mitchell GS: Time-dependent hypoxic ventilatory responses in rats: effects of ketanserin and 5-carboxamidotryptamine. Am J Physiol Regul Integr Comp Physiol 1999, 277: R658-66.
8. Bach KB, Mitchell GS: Hypoxia-induced long-term facilitation of respiratory activity is serotonin dependent. Respir Physiol 1996, 104: 251-60. 10.1016/0034-5687(96)00017-5
9. Pokorski M: Control of Breathing. In Rehabilitation of the Patient with Respiratory Disease. Edited by: Cherniack NS, Altose MD, Homma I. McGraw-Hill: New York; 1999:69-86.
10. Erickson JT, Millhorn DE: Hypoxia and electrical stimulation of the carotid sinus nerve induce Fos-like immonoreactivity within catecholaminergic and serotoninergic neurons of the rat brainstem. J Comp Neurol 1994, 348: 161-82. 10.1002/cne.903480202
11. Teppema LJ, Veening JG, Kranenburg A, Dahan A, Berkenbosh A, Olievier C: Expression of c-fos in the rat brainstem after exposure to hypoxia and to normoxic and hyperoxic hypercapnia. J Comp Neurol 1997, 388: 169-90. 10.1002/(SICI)1096-9861(19971117)388:2<169::AID-CNE1>3.0.CO;2-#
12. Habeck JO, Pallot DJ, Kummer W: Serotonin immunoreactivity in the carotid body of adult humans. Histol Histopathol 1994, 9: 227-32.
13. Grönblad M, Liesi P, Rechardt L: Serotonin-like immunoreactivity in rat carotid body. Brain Res 1983, 276: 348-50. 10.1016/0006-8993(83)90745-X
14. Zhang M, Nurse CA: Does endogenous 5-HT mediate spontaneous rhythmic activity in chemoreceptor clusters of rat carotid body? Brain Res 2000, 872: 199-203. 10.1016/S0006-8993(00)02499-9
15. Sapru HN, Krieger AJ: Effect of 5-hydroxytryptamine on the peripheral chemoreceptors in the rat. Res Commun Chem Pathol Pharmacol 1977, 16: 245-50.
16. Nishi K: The action of 5-hydroxytryptamine on chemoreceptor discharges of the cat's carotid body. Br J Pharmacol 1975, 55: 27-40. 10.1111/j.1476-5381.1975.tb07606.x
17. Peng YJ, Yuan G, Jacono FJ, Kumar GK, Prabhakar NR: 5-HT evokes sensory long-term facilitation of rodent carotid body via activation of NADPH oxidase. J Physiol 2006, 576: 289-95. 10.1113/jphysiol.2006.116020
18. Carley D, Radulovacki M: Role of peripheral serotonin in the regulation of central sleep apneas in rats. Chest 1999, 115: 1397-401. 10.1378/chest.115.5.1397
19. Piomelli D, Greengard P: Lipoxygenase metabolites of arachidonic acid in neuronal signalling. Trends Pharmacol Sci 1990, 11: 367-73. 10.1016/0165-6147(90)90182-8
20. Stubbs CD, Smith AD: The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta 1984, 779: 89-137. 10.1016/0304-4157(84)90005-4
21. de Boer A, van der Sandt I, Gaillard P: The role of drug transporters at the blood brain barrier. Annul Rev Pharmacol Toxicol 2003, 43: 629-56. 10.1146/annurev.pharmtox.43.100901.140204
22. Habgood MD, Begley DJ, Abbot N: Determinants of passive drug entry into the central nervous system. Cell Mol Neurobiol 2000, 20: 231-53. 10.1023/A:1007001923498
23. Xu X, de Pergola G, Eriksson PS, Fu L, Carlsson B, Yang S, Eden S, Bjorntorp P: Postreceptor events involved in the upregulation of beta-adrenergic receptor mediated lipolysis by testosterone in rat white adipocytes. Endocrynology 1993, 132: 1651-7. 10.1210/en.132.4.1651
24. Hilaire G, Morin D, Lajard A-M, Minteau R: Changes in serotonin metabolism may elicit obstructive apnoea in the newborn rat. J Physiol 1993, 466: 367-82.
25. Mazzatenta A, Di Giulio C, Pokorski M: Interaction of arachidonic acid with electrogenic properties of mouse chemosensory neurons. Eur J Med Res 2010. (in this volume)
26. Zajac D, Matysiak Z, Czarnocki Z, Pokorski M: Membrane association of N-oleoyl-dopamine in rat brain. J Physiol Pharmacol 2006,57(Suppl 4):403-8.
27. Scherrmann J-M: Drug delivery to brain via the blood-brain barrier. Vasc Pharmacol 2002, 38: 349-54. 10.1016/S1537-1891(02)00202-1
28. Chu C, Huang S, De Petrocellis L, Bisogno T, Ewing SA, Miller JD, Zipkin RE, Daddario N, Appendino G, Di Marzo V, Walker JM: N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J Biol Chem 2003, 278: 13633-9. 10.1074/jbc.M211231200
29. Bisogno T, Melck D, De Petrocellis L, Bobrov MYu, Gretskaya NM, Bezuglov VV, Sitachitta N, Gerwick WH, Di Marzo V: Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Biochem Biophys Res Commun 1998, 248: 515-22. 10.1006/bbrc.1998.8874
30. Maione S, De Petrocellis L, de Novellis V, Schiano Moriello A, Petrosino S, Palazzo E, Sca Rossi F, Wood-ward DF, Di Marzo V: Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors. Br J Pharmacol 2007, 150: 766-81. 10.1038/sj.bjp.0707145
31. Pokorski M, Zajac D, Kapuscinski A, Matysiak Z, Czarnocki Z: Accumulation of radiolabeled N-oleoyl-dopamine in the rat carotid body. Adv Exp Med Biol 2006, 580: 173-8. 10.1007/0-387-31311-7-26
32. Zajac D, Pokorski M: N-oleoyl-dopamine and carotid body chemosensory responses in the rat. 86th Annual Meeting of the German Physiological Society, March 25-28, 2007, Hannover, Germany; Acta Physiologica 2007,189(Suppl 653):O17-6. p.66 (Abstract)
33. 2 receptor. Respir Physiol Neurobiol 2005, 145: 135-42. 10.1016/j.resp.2004.10.002